日期 | 股東名稱 | 披露原因 | 買入/賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
07/06/2024 | UBS Group AG | 1104(L) | +38,151,763(L) | 496,899,369(L) 345,466,237(S) | 13.21 9.18 | |
06/06/2024 | UBS Group AG | 1306(L) | 44,421,009(L) | 466,851,680(L) 345,647,737(S) | 12.41 9.19 | |
04/06/2024 | UBS Group AG | 1306(L) | 6,194,499(L) | 477,573,094(L) 347,478,820(S) | 12.70 9.24 | |
31/05/2024 | UBS Group AG | 1305(L) | 16,341,978(L) | 476,274,107(L) 345,776,737(S) | 12.66 9.19 | |
29/05/2024 | UBS Group AG | 1306(L) | 27,375,942(L) | 464,715,344(L) 348,256,803(S) | 12.35 9.26 | |
27/05/2024 | UBS Group AG | 1305(L) | 44,032,976(L) | 456,854,958(L) 339,189,506(S) | 12.15 9.02 | |
21/05/2024 | UBS Group AG | 1306(L) | 36,144,726(L) | 468,010,118(L) 347,063,368(S) | 12.44 9.23 | |
15/05/2024 | UBS Group AG | 1305(L) | 36,704,516(L) | 459,978,822(L) 343,803,002(S) | 12.23 9.14 | |
08/05/2024 | UBS Group AG | 1305(L) | 33,428,041(L) | 459,189,005(L) 339,258,002(S) | 12.21 9.02 | |
06/05/2024 | UBS Group AG | 1306(L) | 7,635,760(L) | 452,628,915(L) 339,305,002(S) | 12.03 9.02 | |
03/05/2024 | UBS Group AG | 1305(L) | 38,178,801(L) | 455,885,777(L) 343,859,864(S) | 12.12 9.14 | |
02/05/2024 | UBS Group AG | 1101(L) | +3,569,500(L) | HKD2.939(L) | 452,878,777(L) 342,571,864(S) | 12.04 9.11 |
30/04/2024 | UBS Group AG | 1205(L) | -14,439,651(L) | 440,966,418(L) 338,692,002(S) | 11.72 9.00 | |
29/04/2024 | UBS Group AG | 1306(L) | 26,294,621(L) | 459,198,679(L) 342,571,864(S) | 12.21 9.11 | |
24/04/2024 | UBS Group AG | 1306(L) | 17,380,622(L) | 471,609,660(L) 342,571,864(S) | 12.54 9.11 | |
15/04/2024 | UBS Group AG | 1104(L) | +31,986,991(L) | 483,005,578(L) 349,908,364(S) | 12.84 9.30 | |
12/04/2024 | UBS Group AG | 1205(L) | -22,854,759(L) | 449,304,087(L) 342,003,864(S) | 11.94 9.09 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | 刘殿波 | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Life Sciences Group Ltd | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Ginkgo (PTC) Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Ginkgo (PTC) Limited | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Pharma Holdings Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Luye Life Sciences Group Ltd | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Nelumbo Investments Limited | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | Shorea LBG | 1312(L) | 8,544,000(L) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
10/04/2024 | UBS Group AG | 1213(L) | -16,160,500(L) | 472,981,078(L) 342,159,864(S) | 12.57 9.10 | |
10/04/2024 | 刘殿波 | 1503(S) | -8,544,000(S) | 1,259,196,703(L) 192,317,950(S) | 33.47 5.11 | |
09/04/2024 | UBS Group AG | 1104(L) | +3,392,862(L) | 489,143,078(L) 349,703,364(S) | 13.00 9.30 | |
04/04/2024 | UBS Group AG | 1205(L) | -6,316,500(L) | 483,718,078(L) 342,664,864(S) | 12.86 9.11 | |
02/04/2024 | UBS Group AG | 1104(L) | +6,316,500(L) | 491,522,578(L) 349,703,364(S) | 13.07 9.30 | |
29/03/2024 | UBS Group AG | 1205(L) | -6,316,500(L) | 483,711,216(L) 347,236,002(S) | 12.86 9.23 | |
27/03/2024 | UBS Group AG | 1305(L) | 5,449,187(L) | 491,095,828(L) 351,208,864(S) | 13.06 9.34 | |
26/03/2024 | UBS Group AG | 1104(L) | +9,709,362(L) | 496,904,342(L) 358,247,364(S) | 13.21 9.52 | |
1 2 3 4 5 |
備註: | (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。 |
(S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。 | |
(P) - 可供借出的股份 | |
即時報價更新時間為 01/11/2024 17:06 | |
港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
新聞
股票
期貨期權
權證
ETF
A股
外匯黃金
加密貨幣
基金
MPF